Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Average Recommendation of “Moderate Buy” by Brokerages
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month […]
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month […]
